4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-000806
COO and General Counsel sold 37,184 shares at an average $19.80 ($736,059)
- COO and General Counsel acquired 100,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'Brien Patrick · COO and General Counsel
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-04 | Grant or award : show line 1 in the form 10b5-1 | +100,000 | 564,385 | D | ||
| 2025-01-06 | Sale : show line 2 in the form 10b5-1 | −19,658 | $19.69 | $387,066 | 544,727 | D |
| 2025-01-06 | Sale : show line 3 in the form 10b5-1 | −9,526 | $20.10 | $191,473 | 535,201 | D |
| 2025-01-07 | Sale : show line 4 in the form 10b5-1 | −8,000 | $19.69 | $157,520 | 527,201 | D |
| Open-market sales · 37,184 sh · avg $19.80 · $736,059 | ||||||
Loading xslF345X05/wk-form4_1736303281.xml…